CV Sciences, Inc. Announces New Distribution Agreement with GNC
January 05, 2022 at 08:00 am
Share
CV Sciences, Inc. announced a major new distribution agreement with GNC. Beginning in early 2022, consumers will be able to purchase the Company's top selling ingestible products under the +PlusCBD™ brand in 770 GNC locations. The initial product assortment will include the following +PlusCBD™ items: Extra Strength Formula; Cherry Mango Gummies – 10mg CBD per gummy, 30 count; Extra Strength Formula; Softgels – 15mg per serving, 30 count; Extra Strength; Peppermint Liquid – 10mg per serving; Raspberry Sleep Gummies – 10mg per gummy with Magnolia, Lemon Balm & Melatonin, 30 count; Strawberry Lemonade Calm Gummies – 10mg per gummy with L-Theanine & 5-HTP, 30 count.
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business to business-to-consumer. It operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands: +PlusCBD and Cultured Foods in the healthcare market sector: nutraceutical, beauty care, specialty foods, and pet products. +PlusCBD branded products are sold at select retail locations throughout the United States. Cultured Foods brand provides a variety of plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience. It manufactures encapsulated softgels and tinctures for the supplement and nutrition industry.
CV SCIENCES, INC. 
